Acorda appoints Jane Wasman international president
This article was originally published in Scrip
Executive Summary
Acorda Therapeutics, a biotech company focused on neurological conditions, has named Jane Wasman international president. Ms Wasman most recently served as Acorda's chief of strategic development and general counsel.